9660398

Source:http://linkedlifedata.com/resource/pubmed/id/9660398

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034693, umls-concept:C0205355, umls-concept:C0207072, umls-concept:C0270611, umls-concept:C0301630, umls-concept:C0475224, umls-concept:C0683174, umls-concept:C0740391
pubmed:issue	7
pubmed:dateCreated	1998-7-30
pubmed:abstractText	Glial cell line-derived neurotrophic factor (GDNF) plays important roles in the survival and recovery of some mature neurons under pathological conditions. However, the effect of GDNF in ameliorating ischemic brain injury has not been well documented. Therefore, we investigated a possible effect of GDNF on the changes of infarct size, brain edema, DNA fragmentation, and immunoreactivities for caspases after permanent middle cerebral artery occlusion (MCAO) in rats.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0235266
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cysteine Endopeptidases, http://linkedlifedata.com/resource/pubmed/chemical/Gdnf protein, rat, http://linkedlifedata.com/resource/pubmed/chemical/Glial Cell Line-Derived..., http://linkedlifedata.com/resource/pubmed/chemical/Nerve Growth Factors, http://linkedlifedata.com/resource/pubmed/chemical/Nerve Tissue Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	0039-2499
pubmed:author	pubmed-author:AbeKK, pubmed-author:HayashiTT, pubmed-author:ItoyamaYY, pubmed-author:KitagawaHH, pubmed-author:KogaNN, pubmed-author:MitsumotoYY
pubmed:issnType	Print
pubmed:volume	29
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1417-22
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:9660398-Administration, Topical, pubmed-meshheading:9660398-Animals, pubmed-meshheading:9660398-Arterial Occlusive Diseases, pubmed-meshheading:9660398-Body Water, pubmed-meshheading:9660398-Brain, pubmed-meshheading:9660398-Brain Edema, pubmed-meshheading:9660398-Brain Ischemia, pubmed-meshheading:9660398-Cerebral Arteries, pubmed-meshheading:9660398-Cerebral Infarction, pubmed-meshheading:9660398-Cysteine Endopeptidases, pubmed-meshheading:9660398-DNA Fragmentation, pubmed-meshheading:9660398-Genetic Techniques, pubmed-meshheading:9660398-Glial Cell Line-Derived Neurotrophic Factor, pubmed-meshheading:9660398-Immunohistochemistry, pubmed-meshheading:9660398-Male, pubmed-meshheading:9660398-Nerve Growth Factors, pubmed-meshheading:9660398-Nerve Tissue Proteins, pubmed-meshheading:9660398-Neuroprotective Agents, pubmed-meshheading:9660398-Rats, pubmed-meshheading:9660398-Rats, Wistar
pubmed:year	1998
pubmed:articleTitle	Reduction of ischemic brain injury by topical application of glial cell line-derived neurotrophic factor after permanent middle cerebral artery occlusion in rats.
pubmed:affiliation	Department of Neurology, Tohoku University School of Medicine, Sendai, Japan.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't